Tumor Targeted Sickle Erythroid Precursors, Progenitors and Hematopoietic Stem Cells, Induced Pluripotent Stem Cells, Microparticles and Liposomes for Treatment of Cancer
US2015037297A1
Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors
US2014088020A1
Composition and Methods for Treatment of Cancer
US2013021346A1
Knowledge acquisition nexus for facilitating concept capture and promoting time on task
US2012195869A1
Sickled erythrocytes with anti-tumor agents induce tumor vaso-occlusion and tumoricidal effects
US2012148628A1
Compositions and methods for treatment of cancer
US2011059901A1
Compositions and Methods for Treatment of Neoplastic Disease
WO2007143451A2
Targeted delivery of oncolytic viruses, anti-tumor proteins, plasmids, toxins, hemolysins & chemotherapy
US2009162315A1
Enterotoxin gene cluster (egc) superantigens to treat malignant disease
WO03094846A2
Intrathecal and intratumoral superantigens to treat malignant disease
AU3495499A
Tumor cells with increased immunogenicity and uses thereof
WO9826747A2
Superantigen based methods and compositions for treatment of diseases
WO9736614A1
Polymerized staphylococcal protein a for treatment of diseases
WO9420124A1
Method of cancer treatment
CA2157379A1
Method of cancer treatment
WO9324136A1
Tumor killing effects of enterotoxins, superantigens, and related compounds
AU4526593A
Tumor killing effects of enterotoxins, superantigens, and related compounds
